Andra AP-fonden’s Gilead Sciences GILD Stock Holding History

Andra AP-fonden’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$31M	Sell	222,601 -260,199	-54%	-$36.4M	0.37%	41
2025 Q4	$59.3M	Sell	482,800 -114,700	-19%	-$13.9M	0.73%	24
2025 Q3	$66.3M	Buy	597,500 +19,700	+3%	+$2.24M	0.85%	11
2025 Q2	$64.1M	Buy	577,800 +337,100	+140%	+$35.9M	0.89%	13
2025 Q1	$27M	Sell	240,700 -81,100	-25%	-$8.37M	0.44%	63
2024 Q4	$29.7M	Sell	321,800 -76,700	-19%	-$6.91M	0.48%	47
2024 Q3	$33.4M	Sell	398,500 -18,200	-4%	-$1.39M	0.49%	51
2024 Q2	$28.6M	Sell	416,700 -156,200	-27%	-$10.4M	0.48%	51
2024 Q1	$42M	Buy	+572,900	New	+$44.1M	0.75%	22
2023 Q3	–	Sell	-233,400	Closed	-$18M	–	391
2023 Q2	$18M	Sell	233,400 -35,300	-13%	-$2.82M	0.46%	4
2023 Q1	$22.3M	Buy	268,700 +93,600	+53%	+$7.75M	0.58%	2
2022 Q4	$15M	Buy	175,100 +9,200	+6%	+$729K	0.46%	11
2022 Q3	$10.2M	Buy	165,900 +5,200	+3%	+$328K	0.34%	46
2022 Q2	$9.93M	Buy	+160,700	New	+$9.95M	0.28%	84
2021 Q4	$11.2M	Sell	154,600 -24,000	-13%	-$1.65M	0.23%	172
2021 Q3	$12.5M	Buy	178,600 +10,000	+6%	+$703K	0.26%	102
2021 Q2	$11.6M	Buy	168,600 +65,800	+64%	+$4.39M	0.24%	125
2021 Q1	$6.64M	Sell	102,800 -30,800	-23%	-$1.99M	0.15%	346
2020 Q4	$7.78M	Buy	133,600 +19,100	+17%	+$1.15M	0.17%	282
2020 Q3	$7.24M	Sell	114,500 -5,800	-5%	-$402K	0.2%	196
2020 Q2	$9.26M	Sell	120,300 -7,600	-6%	-$582K	0.27%	37
2020 Q1	$9.56M	Buy	127,900 +10,600	+9%	+$732K	0.35%	7
2019 Q4	$7.62M	Sell	117,300 -1,200	-1%	-$78.1K	0.22%	91
2019 Q3	$7.51M	Sell	118,500 -16,000	-12%	-$1.05M	0.22%	78
2019 Q2	$9.09M	Sell	134,500 -10,300	-7%	-$678K	0.26%	16
2019 Q1	$9.41M	Buy	+144,800	New	+$9.62M	0.27%	21
2018 Q3	$14.4M	Buy	187,000 +8,100	+5%	+$612K	0.37%	4
2018 Q2	$12.7M	Buy	178,900 +17,600	+11%	+$1.24M	0.34%	5
2018 Q1	$12.2M	Buy	161,300 +59,600	+59%	+$4.74M	0.32%	6
2017 Q4	$7.29M	Buy	101,700 +23,300	+30%	+$1.77M	0.17%	167
2017 Q3	$6.35M	Sell	78,400 -8,700	-10%	-$665K	0.15%	174
2017 Q2	$6.17M	Sell	87,100 -5,100	-6%	-$339K	0.15%	174
2017 Q1	$6.26K	Buy	92,200 +4,200	+5%	+$295K	0.15%	183
2016 Q4	$6.3M	Sell	88,000 -6,000	-6%	-$446K	0.17%	161
2016 Q3	$7.44M	Buy	94,000 +10,000	+12%	+$812K	0.2%	141
2016 Q2	$7.01M	Sell	84,000 -600	-0.7%	-$53.2K	0.18%	147
2016 Q1	$7.77M	Sell	84,600 -2,800	-3%	-$253K	0.2%	131
2015 Q4	$8.84M	Sell	87,400 -2,400	-3%	-$250K	0.25%	112
2015 Q3	$8.82M	Buy	89,800 +9,500	+12%	+$1.06M	0.26%	100
2015 Q2	$9.4M	Sell	80,300 -16,300	-17%	-$1.78M	0.27%	95
2015 Q1	$9.48M	Sell	96,600 -56,400	-37%	-$5.73M	0.27%	96
2014 Q4	$14.4M	Buy	153,000 +12,400	+9%	+$1.28M	0.33%	70
2014 Q3	$15M	Sell	140,600 -14,700	-9%	-$1.44M	0.35%	71
2014 Q2	$12.9M	Sell	155,300 -187,700	-55%	-$14.6M	0.28%	102
2014 Q1	$24.3M	Buy	343,000 +112,200	+49%	+$8.8M	0.56%	27
2013 Q4	$17.3M	Buy	230,800 +16,800	+8%	+$1.17M	0.41%	49
2013 Q3	$13.4M	Sell	214,000 -9,200	-4%	-$550K	0.34%	63
2013 Q2	$11.4M	Buy	+223,200	New	+$11.6M	0.3%	79

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Andra AP-fonden's GILD Position: Q1 2026 in Review

Andra AP-fonden reduced its Gilead Sciences (GILD) stake by 54% in Q1 2026, selling an estimated $36.4M and leaving 222,601 shares worth $31M. The position accounts for 0.37% of the portfolio, ranked #41.

Andra AP-fonden first reported a position in GILD in Q2 2013 and has held it in 48 quarters since. The position peaked at $66.3M in Q3 2025. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Andra AP-fonden held 222,601 shares of Gilead Sciences worth $31M as of Q1 2026.
Andra AP-fonden sold 260,199 Gilead Sciences shares in Q1 2026, an estimated $36.4M.
Gilead Sciences made up 0.37% of Andra AP-fonden's portfolio in Q1 2026, its #41 holding.
Andra AP-fonden first reported a position in Gilead Sciences in Q2 2013 and has held it in 48 quarters since.
Andra AP-fonden's Gilead Sciences position peaked at $66.3M in Q3 2025.
2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Andra AP-fonden's 13F filing for Q1 2026, filed 8 May 2026.